Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

The Bullish Case for Ethereum Hinges on the Answer to One Question

An on-time launch of Ethereum 2.0 will be a catalyst for Ethereum in 2022. However, with monetary policy tightening, will investors move away from risk-on assets.

Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022

Retail investors continue to drive the price of meme stocks higher. So it's time to look at 10 meme stocks and consider how they'll fare in 2022

Investors Shouldn’t Read Too Much Into BitPay Poll Snubbing Cardano

Cardano will not be the next altcoin listed on BitPay. But ADA-USD remains well-positioned to compete against Ethereum with value that goes beyond price.

Moderna’s Long-Term Benefit Is Cursed by Short-Term Thinking

Moderna dropped after results for its mRNA flu vaccine underwhelmed investors. That proves MRNA stock is suffering from short-term thinking.

Digital World Acquisition Corp. Is More Like a Fundraiser Than an Investment Opportunity

What could possibly go wrong with DWAC stock? Not much if you’re Donald Trump. But there’s plenty that can go sideways for investors.